爱美客(300896)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300896 爱美客

交易中 12-26 13:50:03

{"stockData":{"symbol":"300896","market":"SZ","secType":"STK","nameCN":"爱美客","latestPrice":144.1,"timestamp":1766728203000,"preClose":143.5,"halted":0,"volume":1943264,"delay":0,"changeRate":0.0042,"floatShares":209000000,"shares":303000000,"eps":4.8427,"marketStatus":"交易中","change":0.6,"latestTime":"12-26 13:50:03","open":143,"high":145.58,"low":142.7,"amount":280000000,"amplitude":0.0201,"askPrice":144.28,"askSize":2,"bidPrice":144.1,"bidSize":5,"shortable":0,"etf":0,"ttmEps":4.8427,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1766732400000},"marketStatusCode":2,"adr":0,"adjPreClose":143.5,"symbolType":"stock","openAndCloseTimeList":[[1766712600000,1766719800000],[1766725200000,1766732400000]],"highLimit":157.85,"lowLimit":129.15,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":302592061,"isCdr":false,"pbRate":5.88,"roa":"--","peRate":29.756128,"roe":"14.18%","epsLYR":6.5,"committee":0.107692,"marketValue":43604000000,"turnoverRate":0.0093,"status":0,"floatMarketCap":30058000000},"requestUrl":"/m/hq/s/300896","defaultTab":"news","newsList":[{"id":"2594252481","title":"当爱美客沦为“老登股”","url":"https://stock-news.laohu8.com/highlight/detail?id=2594252481","media":"锦缎","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594252481?lang=zh_cn&edition=full","pubTime":"2025-12-26 08:22","pubTimestamp":1766708522,"startTime":"0","endTime":"0","summary":"爱美客的业绩下滑并非孤立现象。爱美客因此被称为行业内的“利润之王”。凭借高毛利、高复购、强品牌，爱美客一度被市场誉为“医美茅”，在2021年市值突破1700亿元。2025年前三季度，爱美客“嗨体”所在的溶液类板块与“濡白天使”所在的凝胶类产品板块收入分别下滑23.79%和23.99%。2025年10月21日，爱美客宣布成功完成首个化妆品新原料“甘草查尔酮A”的备案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8pOLbos6tzY","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fenghuang_stock","symbols":["300896","BK0251"],"gpt_icon":0},{"id":"2594230828","title":"爱美客（300896）披露部分募集资金投资项目延期公告，12月25日股价上涨0.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2594230828","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594230828?lang=zh_cn&edition=full","pubTime":"2025-12-25 22:57","pubTimestamp":1766674632,"startTime":"0","endTime":"0","summary":"截至2025年12月25日收盘，爱美客报收于143.5元，较前一交易日上涨0.49%，最新总市值为434.22亿元。该股当日开盘142.42元，最高144.16元，最低142.19元，成交额达2.73亿元，换手率为0.91%。近日，爱美客技术发展股份有限公司发布公告称，公司董事会审议通过部分募集资金投资项目延期事项。本次延期未改变项目实施主体、投资用途及规模，不影响公司正常经营，不损害股东利益。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122500036525.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300896","BK0251"],"gpt_icon":0},{"id":"2594235474","title":"爱美客（300896.SZ）公告部分募投项目延期，基因重组蛋白基地项目延期两年","url":"https://stock-news.laohu8.com/highlight/detail?id=2594235474","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594235474?lang=zh_cn&edition=full","pubTime":"2025-12-25 17:28","pubTimestamp":1766654882,"startTime":"0","endTime":"0","summary":"中访网数据 爱美客技术发展股份有限公司于2025年12月25日召开董事会，审议通过了关于部分首次公开发行股票募集资金投资项目延期的议案。“注射用A型肉毒毒素研发项目”的预定可使用状态日期则从2025年12月31日延长至2026年12月31日，延期一年。截至2025年9月30日，基因重组蛋白研发生产基地建设项目已投入募集资金31万元，注射用A型肉毒毒素研发项目已投入募集资金5,376.49万元。此次延期事项已经公司董事会审议通过，无需提交股东大会审议。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20251225/31892224.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0251","300896"],"gpt_icon":0},{"id":"2593485414","title":"股市必读：爱美客（300896）12月23日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2593485414","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593485414?lang=zh_cn&edition=full","pubTime":"2025-12-24 01:00","pubTimestamp":1766509249,"startTime":"0","endTime":"0","summary":"截至2025年12月23日收盘，爱美客报收于142.29元，下跌1.46%，换手率1.34%，成交量2.8万手，成交额4.0亿元。董秘最新回复投资者： 董秘您好，公司股价在低位夯实，股价就像是一棵稚嫩的小草，需要大家共同的小心呵护，请管理层要做好大股东的思想工作，不轻易谈减持！当日关注点来自交易信息汇总：12月23日主力资金净流出4841.89万元，散户资金净流入3084.8万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122400000568.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300896"],"gpt_icon":0},{"id":"2593870104","title":"爱美客：截至2025年12月19日股东人数为61,747户","url":"https://stock-news.laohu8.com/highlight/detail?id=2593870104","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593870104?lang=zh_cn&edition=full","pubTime":"2025-12-22 15:08","pubTimestamp":1766387303,"startTime":"0","endTime":"0","summary":"证券之星消息，爱美客(300896)12月22日在投资者关系平台上答复投资者关心的问题。投资者提问：请问，截至2025年十二月 19日公司的股东总数是多少？谢谢爱美客回复：尊敬的投资者您好，截至2025年12月19日，公司股东人数为61,747户。感谢您对公司的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122200012261.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300896"],"gpt_icon":0},{"id":"2592993354","title":"爱美客：不通过官网微信公众号推送月度经营简报","url":"https://stock-news.laohu8.com/highlight/detail?id=2592993354","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592993354?lang=zh_cn&edition=full","pubTime":"2025-12-17 17:18","pubTimestamp":1765963087,"startTime":"0","endTime":"0","summary":"证券之星消息，爱美客(300896)12月17日在投资者关系平台上答复投资者关心的问题。投资者提问：爱美客官网＂投资者关系＂栏目更新是否及时？是否会通过微信公众号推送月度经营简报（如自由现金流、新品销量）?爱美客回复：尊敬的投资者您好，公司不通过官网、微信公众号推送月度经营简报等公司生产经营信息，公司严格按照深交所相关规定，定期对公司经营情况进行公告，感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121700026884.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300896"],"gpt_icon":0},{"id":"2591671131","title":"从 “女人的茅台” 到“创50”弃子：爱美客陷业绩困局与“童颜针”代理权迷战","url":"https://stock-news.laohu8.com/highlight/detail?id=2591671131","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591671131?lang=zh_cn&edition=full","pubTime":"2025-12-16 10:20","pubTimestamp":1765851642,"startTime":"0","endTime":"0","summary":"相较于2021年高达千亿元的市值巅峰，曾被誉为 “女人的茅台” 的爱美客，如今已风光不再。2024年1月，艾塑菲获得国家药品监督管理局颁发的《医疗器械注册证》，随后产品上市销售，成为国内首款进口“童颜针”。但* ST苏吴对此坚决否认，直指“爱美客与REGEN公司趁人之危、背信弃义”，双方随后分别提起仲裁与反仲裁，这场涉及16亿元的代理权纠纷至今悬而未决。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2025121600010861.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU0181495838.USD","159373","LU0577902454.USD","LU2097828631.EUR","LU1226287875.USD","LU0320764599.SGD","LU1303224171.USD","LU0405327148.USD","LU0823426308.USD","LU0605514214.HKD","LU0873338254.USD","LU0359201612.USD","300896","LU1781817850.SGD","BK0215","LU1008478684.HKD","LU1152091754.HKD","LU1634259557.SGD","LU2097828714.EUR","LU2097828805.USD","600519","LU1769817179.HKD","LU1226287529.USD","SG9999002562.SGD","LU1051768304.USD","LU1688375341.USD","LU1226288170.HKD","LU1979443071.USD","LU1770034418.SGD","LU1993786604.SGD","LU1734074674.USD","LU0594300179.USD","LU1720050803.USD","LU0456846285.SGD","LU2213484517.USD","LU0577902298.EUR","LU1105468828.SGD","LU0228659784.USD","LU1226287792.SGD","LU1226288253.USD","LU2097828557.USD","LU0039217434.USD","LU0328353924.USD","LU1515016050.SGD","LU1969619763.USD","LU1328615791.USD","LU0348805143.USD","LU0594300419.USD","LU1522347837.USD","LU0918141887.USD"],"gpt_icon":0},{"id":"2590750585","title":"爱美客：REGEN公司已向达透医疗送达解约函","url":"https://stock-news.laohu8.com/highlight/detail?id=2590750585","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590750585?lang=zh_cn&edition=full","pubTime":"2025-12-12 15:42","pubTimestamp":1765525335,"startTime":"0","endTime":"0","summary":"证券之星消息，爱美客12月12日在投资者关系平台上答复投资者关心的问题。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121200018816.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300896","BK0251","159891"],"gpt_icon":0},{"id":"2590262560","title":"爱美客：注射用A型肉毒毒素处于排队待审评状态","url":"https://stock-news.laohu8.com/highlight/detail?id=2590262560","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590262560?lang=zh_cn&edition=full","pubTime":"2025-12-11 15:21","pubTimestamp":1765437685,"startTime":"0","endTime":"0","summary":"证券之星消息，爱美客(300896)12月11日在投资者关系平台上答复投资者关心的问题。投资者提问：李冬梅总，贵司注射用A型肉毒毒素，受理编号JXSS2400051，目前评审进度在CDE“审评任务公示”- “补充资料任务公示”中查询不到了，请问是什么原因？爱美客回复：尊敬的投资者您好，经登录国家药品监督管理局药品审评中心官网，在其“审评任务公示”-之“补充资料任务公示”项下，可以查询到注射用A型肉毒毒素处于“排队待审评“状态，感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121100019179.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300896","BK0251"],"gpt_icon":0},{"id":"2590604405","title":"爱美客：截至2025年12月10日股东人数为60,403户","url":"https://stock-news.laohu8.com/highlight/detail?id=2590604405","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590604405?lang=zh_cn&edition=full","pubTime":"2025-12-11 15:21","pubTimestamp":1765437684,"startTime":"0","endTime":"0","summary":"证券之星消息，爱美客(300896)12月11日在投资者关系平台上答复投资者关心的问题。投资者提问：请问，截至2025年十二月 10日公司的股东总数是多少？谢谢爱美客回复：尊敬的投资者您好，截至2025年12月10日，公司股东人数为60,403户。感谢您对公司的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121100019177.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300896"],"gpt_icon":0},{"id":"2590463310","title":"爱美客：用科技成人之美为使命","url":"https://stock-news.laohu8.com/highlight/detail?id=2590463310","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590463310?lang=zh_cn&edition=full","pubTime":"2025-12-09 19:06","pubTimestamp":1765278389,"startTime":"0","endTime":"0","summary":"证券之星消息，爱美客(300896)12月09日在投资者关系平台上答复投资者关心的问题。投资者提问：请问懂秘，公司的企业文化建设如何，可以公布一下不？爱美客回复：尊敬的投资者您好，公司企业文化以“用科技成人之美”为使命，以“让生命有更高的质量和尊严”为愿景。感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120900030832.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300896","BK0251"],"gpt_icon":0},{"id":"2588014797","title":"爱美客：公司肉毒毒素项目目前审评状态为排队待审评","url":"https://stock-news.laohu8.com/highlight/detail?id=2588014797","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588014797?lang=zh_cn&edition=full","pubTime":"2025-12-03 17:36","pubTimestamp":1764754575,"startTime":"0","endTime":"0","summary":"证券之星消息，爱美客(300896)12月03日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘，你好。国家医药监督管理局审评中心网站显示，爱美客公司的肉毒素审批项目，审评阶段的显示灯已经全部完成，是否代表审评工作结束，进入行政审评发证的阶段。爱美客回复：尊敬的投资者您好，公司肉毒毒素项目目前审评状态为排队待审评，感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120300027654.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300896"],"gpt_icon":0},{"id":"2588740841","title":"爱美客：肉毒毒素项目在排队待审评阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2588740841","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588740841?lang=zh_cn&edition=full","pubTime":"2025-12-01 16:31","pubTimestamp":1764577889,"startTime":"0","endTime":"0","summary":"证券之星消息，爱美客(300896)12月01日在投资者关系平台上答复投资者关心的问题。投资者提问：肉毒素项目黄了吗。爱美客回复：尊敬的投资者您好，公司肉毒毒素项目目前在排队待审评阶段，感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120100017292.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300896"],"gpt_icon":0},{"id":"2588174036","title":"爱美客：截至2025年11月28日股东人数为60,928户","url":"https://stock-news.laohu8.com/highlight/detail?id=2588174036","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588174036?lang=zh_cn&edition=full","pubTime":"2025-12-01 16:31","pubTimestamp":1764577889,"startTime":"0","endTime":"0","summary":"证券之星消息，爱美客(300896)12月01日在投资者关系平台上答复投资者关心的问题。投资者提问：请问，截至2025年十一月 28日公司的股东总数是多少？谢谢爱美客回复：尊敬的投资者您好，截至2025年11月28日，公司股东人数为60,928户。感谢您对公司的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120100017291.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300896","BK0251"],"gpt_icon":0},{"id":"2586200070","title":"爱美客：公司产品主要销往民营医疗美容机构","url":"https://stock-news.laohu8.com/highlight/detail?id=2586200070","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586200070?lang=zh_cn&edition=full","pubTime":"2025-11-28 17:27","pubTimestamp":1764322030,"startTime":"0","endTime":"0","summary":"证券之星消息，爱美客11月28日在投资者关系平台上答复投资者关心的问题。我也是爱美客的小股东，请问我们公司领导层，有没有开拓国内的公立医院为客户的意向呢？后续公司会结合政策要求、市场情况等多维度因素综合评估后决定对公立医院市场开拓。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112800025337.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300896","BK0251"],"gpt_icon":0},{"id":"2586575428","title":"爱美客：基因重组蛋白研发生产基地建设项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2586575428","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586575428?lang=zh_cn&edition=full","pubTime":"2025-11-25 16:25","pubTimestamp":1764059139,"startTime":"0","endTime":"0","summary":"证券之星消息，爱美客11月25日在投资者关系平台上答复投资者关心的问题。爱美客回复：尊敬的投资者您好，公司定期报告披露的募投项目名称为“基因重组蛋白研发生产基地建设项目”，该项目的实施内容为建设基因重组蛋白药物重组人胰高血糖样肽-1类似物的生产车间以及其他辅助设施。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112500021157.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300896","BK0251"],"gpt_icon":0},{"id":"2585122706","title":"“医美茅”跌落  简军如何续写爱美客千亿传奇？","url":"https://stock-news.laohu8.com/highlight/detail?id=2585122706","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585122706?lang=zh_cn&edition=full","pubTime":"2025-11-22 07:00","pubTimestamp":1763766000,"startTime":"0","endTime":"0","summary":"　　昔日有着“医美茅”之称的爱美客，在业绩持续下滑、重大仲裁案悬而未决的关键节点，新一届董事会换届工作于日前落下帷幕。　　公司实际控制人、62岁的简军毫无悬念连任董事长及法定代表人，石毅峰、勾丽娜、尹永磊组成的核心管理层保持稳定。2025年上半年，爱美客首次出现业绩负增长，三季度营收5.66亿元、归母净利润3.04亿元，同比分别下滑21.27%和34.61%，前三季度累计营收与净利润跌幅均超20%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2025-11-22/doc-infyfnms6441828.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-11-22/doc-infyfnms6441828.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["300896","BK0251"],"gpt_icon":0},{"id":"2585967192","title":"爱美客：聚焦主业提升核心竞争力","url":"https://stock-news.laohu8.com/highlight/detail?id=2585967192","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585967192?lang=zh_cn&edition=full","pubTime":"2025-11-21 15:12","pubTimestamp":1763709138,"startTime":"0","endTime":"0","summary":"证券之星消息，爱美客11月21日在投资者关系平台上答复投资者关心的问题。谢谢爱美客回复：尊敬的投资者您好，公司高度关注股价波动，其受宏观经济环境、行业政策、市场情绪及公司经营状况等多重因素影响。公司始终坚持长期可持续发展理念，聚焦主营业务，持续优化产品结构，强化创新驱动，不断提升核心竞争力与抗风险能力，夯实企业内在价值，推动业绩稳步增长，切实维护广大股东权益。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112100017310.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300896"],"gpt_icon":0},{"id":"2585950192","title":"爱美客：截至2025年11月20日股东人数为60,941户","url":"https://stock-news.laohu8.com/highlight/detail?id=2585950192","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585950192?lang=zh_cn&edition=full","pubTime":"2025-11-21 15:09","pubTimestamp":1763708957,"startTime":"0","endTime":"0","summary":"证券之星消息，爱美客(300896)11月21日在投资者关系平台上答复投资者关心的问题。投资者提问：请问，截至2025年十一月 20日公司的股东总数是多少？谢谢爱美客回复：尊敬的投资者您好，截至2025年11月20日，公司股东人数为60,941户。感谢您对公司的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112100017272.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300896"],"gpt_icon":0},{"id":"2584911506","title":"爱美客增速从引领到落后：连续4个季度业绩双降 溢价1344%收购童颜针巨头卷入16亿元代理权仲裁案","url":"https://stock-news.laohu8.com/highlight/detail?id=2584911506","media":"新浪证券","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584911506?lang=zh_cn&edition=full","pubTime":"2025-11-19 17:03","pubTimestamp":1763542980,"startTime":"0","endTime":"0","summary":"2025年第三季度，爱美客业绩双降，营收同比下降21.27%，归母净利润同比下降34.61%，至此公司已连续四个季度业绩双降，盈利能力显著减弱。进入2025年，下滑趋势进一步加剧，前三季度营收同比下滑21.49%至18.65亿元，归母净利润同比下降31.05%至10.93亿元。　　为寻增量溢价1344.12%收购“童颜针”母公司致商誉激增 业绩未显著改善反卷入16亿元代理权仲裁案","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/observe/2025-11-19/doc-infxxsmw4605057.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["300896","BK0251"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1766728207719,"stockEarnings":[{"period":"1week","weight":0.0118},{"period":"1month","weight":-0.014},{"period":"3month","weight":-0.2124},{"period":"6month","weight":-0.1612},{"period":"1year","weight":-0.2705},{"period":"ytd","weight":-0.191}],"compareEarnings":[{"period":"1week","weight":0.0215},{"period":"1month","weight":0.0232},{"period":"3month","weight":0.0344},{"period":"6month","weight":0.1564},{"period":"1year","weight":0.1669},{"period":"ytd","weight":0.1814}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"爱美客技术发展股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"61747人(较上一季度增加2.23%)","perCapita":"3378股","listingDate":"2020-09-28","address":"北京市昌平区科技园区白浮泉路10号北控科技大厦4层416B室","registeredCapital":"30259万元","survey":"　　爱美客技术发展股份有限公司的主营业务是生物医用材料及生物医药的研发、生产和销售。公司的主要产品是Ⅲ类医疗器械、注射类皮肤填充剂产品。","listedPrice":118.27},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"爱美客(300896)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供爱美客(300896)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"爱美客,300896,爱美客股票,爱美客股票老虎,爱美客股票老虎国际,爱美客行情,爱美客股票行情,爱美客股价,爱美客股市,爱美客股票价格,爱美客股票交易,爱美客股票购买,爱美客股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"爱美客(300896)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供爱美客(300896)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}